Found: 6
Select item for more details and to access through your institution.
A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 4, p. 1148, doi. 10.3390/pharmaceutics15041148
- By:
- Publication type:
- Article
A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102238
- By:
- Publication type:
- Article
Rational Nanotoolbox with Theranostic Potential for Medicated Pro‐Regenerative Corneal Implants.
- Published in:
- Advanced Functional Materials, 2019, v. 29, n. 38, p. N.PAG, doi. 10.1002/adfm.201903760
- By:
- Publication type:
- Article
ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells.
- Published in:
- Biomedicines, 2020, v. 8, n. 6, p. 170, doi. 10.3390/biomedicines8060170
- By:
- Publication type:
- Article
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0198038
- By:
- Publication type:
- Article
A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib‐resistant ROR1<sup>+</sup> CLL cells.
- Published in:
- EJHaem, 2021, v. 2, n. 3, p. 498, doi. 10.1002/jha2.232
- By:
- Publication type:
- Article